Exact Mass: 417.05496100000005
Exact Mass Matches: 417.05496100000005
Found 72 metabolites which its exact mass value is equals to given mass value 417.05496100000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Metosulam
C14H13Cl2N5O4S (417.0065278000001)
Selective post-emergence herbicide used on cereals against broad-leaved weeds Selective post-emergence herbicide used on cereals against broad-leaved weed
2-Deoxy-5-hydroxymethylcytidine-5-diphosphate
C10H17N3O11P2 (417.03383119999995)
Grixazone B
C18H15N3O7S (417.06306800000004)
A cysteine derivative that is the S-(2-amino-8-carboxy-3-oxo-3H-phenoxazin-1-yl) derivative of N-acetyl-L-cysteine.
Ochratoxin A methyl ester
C21H20ClNO6 (417.0979090000001)
Pexidartinib
C20H15ClF3N5 (417.09680160000005)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Triazolo-benzophenone
C19H17Cl2N5O2 (417.07592420000003)
Cc1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(N)c(Cl)c1O
C18H16ClN5O3S (417.06623360000003)
3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE
C19H13F2N3O2S2 (417.04172220000004)
(+)-(3R,5R,6S,8S)-3-dihydrodiscorhabdin A trifluoroacetate
C18H16BrN3O2S (417.01465360000003)
2-[(3,4-Dihydro-1-oxo-3-methyl-5-chloro-8-hydroxy-1H-2-benzopyran-7-yl)carbonylamino]-3-phenylpropanoic acid methyl ester
C21H20ClNO6 (417.0979090000001)
Coptisine sulfate
C19H15NO8S (417.05183500000004)
Coptisine Sulfate is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM[1]. Coptisine Sulfate is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM[1].
Metosulam
C14H13Cl2N5O4S (417.0065278000001)
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3172
dichlorodihydroxybis(isopropylamine)platinum
C6H20Cl2N2O2Pt (417.05496100000005)
N-(5-CHLOROBENZO[D][1,3]DIOXOL-4-YL)-7-FLUORO-5-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)QUINAZOLIN-4-AMINE
C20H17ClFN3O4 (417.08915640000004)
5,6-Dihydrobis[1,3]benzodioxolo[5,6-a:5,6-g]quinolizinium sulfate (1:1)
C19H15NO8S (417.05183500000004)
trimethyl-[[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolo[2,3-b]pyridin-3-yl]methyl]azanium,iodide
6-BROMO-2-(3,4,5-TRIMETHOXY-PHENYL)-QUINOLINE-4-CARBOXYLICACID
C19H16BrNO5 (417.02117860000004)
Bretazenil
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
[2-carbonochloridoyl-4-(2,4-difluorophenyl)phenyl] 4-nitrobenzoate
Sulfatolamide
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AE - Sulfonamides C254 - Anti-Infective Agent > C2166 - Combination Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
4-Methylumbelliferyl2-sulfamino-2-deoxy-a-D-gluc]
C16H19NO10S (417.07296340000005)
Tetraethylenepentamine polyisobutylene succinimide,molybdenum complex,sulfurized
C12H25MoN5O5------ (417.09096500000004)
3-[[4-[(6,7-dichlorobenzothiazol-2-yl)azo]-3-methylphenyl]ethylamino]propiononitrile
C19H17Cl2N5S (417.0581662000001)
Methyl 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate
C18H16BrN3O2S (417.01465360000003)
3-[4-[(5,6-dichloro-1,3-benzothiazol-2-yl)diazenyl]-N-ethyl-3-methylanilino]propanenitrile
C19H17Cl2N5S (417.0581662000001)
4-[(2E)-2-(2-amino-3-chloro-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-N-pyridin-2-ylbenzenesulfonamide
C18H16ClN5O3S (417.06623360000003)
4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]furan-2-Yl}-2-(Trifluoromethyl)benzenesulfonamide
C15H10F3N3O4S2 (417.00648160000003)
Pexidartinib
C20H15ClF3N5 (417.09680160000005)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
6-bromo-2-(4-methylphenyl)-N-(pyridin-3-yl)quinoline-4-carboxamide
kaempferol 3-O-beta-D-xyloside(1-)
C20H17O10- (417.08216819999996)
An organic anion obtained by selective deprotonation of the 7-hydroxy group of kaempferol 3-O-beta-D-xyloside; major species at pH 7.3.
1-O-[[2-(Sulfoamino)-2,4-dideoxy-D-glucopyranose]-4-yl]-4,5-didehydro-6-oxo-4-deoxy-beta-D-glucopyranose
(4aS,5S,12aS)-1,4a,5,8,10,11,12a-heptahydroxy-3,12-dioxo-4,5-dihydrotetracene-2-carboxamide
C19H15NO10 (417.06959300000005)
3-[2-(3,4-Dihydroxy-phenyl)-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl]-benzonitrile
N-(2-phenylethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide
C19H14F3N5OS (417.08711100000005)
1-(4-ethoxyphenyl)-2-[6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-4-oxo-1H-pyrimidin-2-yl]guanidine
C17H19N7O2S2 (417.10415939999996)
4-(1,3-Benzothiazol-2-ylthio)butanoic acid [2-[(3-cyano-2-thiophenyl)amino]-2-oxoethyl] ester
C18H15N3O3S3 (417.02755200000007)
Acetic acid [4-[acetyl-(4-chlorophenyl)sulfonylamino]-1-naphthalenyl] ester
C20H16ClNO5S (417.0437676000001)
N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide
(3E)-3-(4-bromobenzylidene)-1-(2-hydroxyphenyl)-5-phenyl-1,3-dihydro-2H-pyrrol-2-one
ammine(cyclohexylamine)dihydroxodichloroplatinum(IV)
C6H20Cl2N2O2Pt (417.05496100000005)
3-[(5E)-5-[[3-[(4-fluorophenyl)methoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid
(3S,4R,5R,6R)-2-[3-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5-yl]-3,4,5-trihydroxyoxazinane-6-carboxylic acid
C14H13Cl2N5O6 (417.02428580000003)
[3-[(E)-(2-Amino-4-oxo-1,3-thiazol-5-ylidene)methyl]phenyl] 4-acetamidobenzenesulfonate
C18H15N3O5S2 (417.04531000000003)
2-deoxy-5-hydroxymethyl-CDP
C10H17N3O11P2 (417.03383119999995)
A pyrimidine 2-deoxyribonucleoside 5-diphosphate that is 2-deoxycytidine 5-diphosphate (CDP) substituted by a hydroxymethyl group at position 5.
2-[(3s,3ar)-7-chloro-3a-{[(2s,3s,5s,6r)-3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl]oxy}-3-hydroxy-3h-cyclopenta[a]inden-5-yl]acetonitrile
C21H20ClNO6 (417.0979090000001)
8-amino-9-({2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxophenoxazine-2-carboxylic acid
C18H15N3O7S (417.06306800000004)
2-{4-chloro-3a-[(3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl)oxy]-3-hydroxy-3h-cyclopenta[a]inden-5-yl}acetonitrile
C21H20ClNO6 (417.0979090000001)
2-[(3s,3ar)-4-chloro-3a-{[(2s,3s,5s,6r)-3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl]oxy}-3-hydroxy-3h-cyclopenta[a]inden-5-yl]acetonitrile
C21H20ClNO6 (417.0979090000001)
2-{7-chloro-3a-[(3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl)oxy]-3-hydroxy-3h-cyclopenta[a]inden-5-yl}acetonitrile
C21H20ClNO6 (417.0979090000001)
(3s,6s,10s)-5-bromo-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,13,15,17(21)-hexaene-6,13-diol
C18H16BrN3O2S (417.01465360000003)
n-[(2r,3r,9e)-10-chloro-2-(6,6-dichlorohex-5-en-3-yn-1-yl)-1-methoxy-1-oxodec-9-en-7-yn-3-yl]ethanimidic acid
8-amino-9-{[(2r)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulfanyl}-7-oxophenoxazine-2-carboxylic acid
C18H15N3O7S (417.06306800000004)
(3s,6s,8r,10s)-5-bromo-6-hydroxy-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,14(21),16-pentaen-13-one
C18H16BrN3O2S (417.01465360000003)